as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
7.54%
Downside
0.24%
Upside
52 Week's Low
52 Week's High
37.60%
Downside
747.31%
Upside
Check Mersana Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$40.1M
EPS (TTM)
-1.86
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.78
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-70.6M
Revenue (TTM)
34.8M
Profit Margin
-212.94%
Return On Equity TTM
-505.14%
Track how Mersana Therapeutics Inc P/E has moved over time to understand its valuation trends.
Mersana Therapeutics Inc in the last 5 years
Lowest (-136.51x)
September 30, 2021
Today (-1.78x)
November 8, 2025
Industry (-0.81x)
November 8, 2025
Highest (-1.45x)
September 30, 2025
Today’s Price to Earnings Ratio: -1.78x
Compare market cap, revenue, PE, and other key metrics of Mersana Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $40.1M | -98.5% | -1.78 | -212.94% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
The Mersana Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mersana Therapeutics Inc investment value today
Current value as on today
₹18,103
Returns
Returns from Mersana Therapeutics Inc Stock
Dollar Returns*
₹5,107 (+5.11%)
Based on 15 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 15 analysts, 80% of analysts recommend a 'BUY' rating for Mersana Therapeutics Inc. Average target price of $28.29
Get share price movements and forecasts by analysts on Mersana Therapeutics Inc.
What analysts predicted
70.48%UPSIDE
Target Price
$28.29
Current Price
$8.35
Analyzed by
15 Analysts
Target
$28.29
Mersana Therapeutics Inc target price $28.29, a slight upside of 70.48% compared to current price of $8.35. According to 15 analysts rating.
Search interest for Mersana Therapeutics Inc Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 2.75M → 3.05M (in $), with an average increase of 9.9% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 992.4%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 240.0%
Profit Down
![]()
Netprofit is down for the last 4 quarters, -11.50M → -24.29M (in $), with an average decrease of 31.5% per quarter
Price Dip
![]()
In the last 7 days, MRSN stock has moved down by -16.1%
| Organisation | Mersana Therapeutics Inc |
| Headquarters | 840 Memorial Drive, Cambridge, MA, United States, 02139 |
| Industry | Health Technology |
| CEO | Dr. Martin H. Huber M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Mikhail Papisov Ph.D. | Co-Founder |
Mr. Ashish Mandelia | VP & Chief Accounting Officer |
Mr. Chuck Miller | Senior Vice President of Regulatory Affairs |
Dr. Marc Damelin Ph.D. | Exe. Director and Head of Biology, Oncology, Antibody-Drug Conjugate ADC Discovery & Develop. |
Dr. Martin H. Huber M.D. | President, CEO & Director |
Mr. Brian C. DeSchuytner | Senior VP, CFO & COO |
Dr. Timothy B. Lowinger Ph.D. | Senior VP and Chief Science & Technology Officer |
Ms. Alejandra Veronica Carvajal J.D. | Senior VP, Secretary & Chief Legal Officer |
Dr. Mohan Bala Ph.D. | Senior VP & Chief Development Officer |
Mr. Jason Fredette | Senior Vice President of Investor Relations & Corporate Communications |
Mersana Therapeutics Inc share price today is $8.35 as on at the close of the market. Mersana Therapeutics Inc share today touched a day high of $8.37 and a low of $7.72.
Mersana Therapeutics Inc share touched a 52 week high of $70.75 on and a 52 week low of $5.21 on . Mersana Therapeutics Inc stock price today i.e. is closed at $8.35,which is 88.20% down from its 52 week high and 60.27% up from its 52 week low.
Mersana Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Mersana Therapeutics Inc (MRSN) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Mersana Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mersana Therapeutics Inc share’s latest price of $8.35 as on November 8, 2025 at 2:29 am IST, you will get 1.1976 shares of Mersana Therapeutics Inc. Learn more about
fractional shares .
Mersana Therapeutics Inc stock has given -98.5% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?